DSIP (Delta Sleep-Inducing Peptide) Best for: Sleep disruption and nighttime recovery Mechanism: DSIP is a naturally occurring nonapeptide that promotes slow-wave (delta) sleep by interacting with GABAergic and glutamatergic (NMDA) neurochemical systems, reducing cortisol and ACTH output without forcing sedation
Ultimately, 706 participants met the eligibility criteria and were randomly assigned to one of several treatment arms: once-weekly subcutaneous injections of Cagrilintide at doses of 0.3, 0.6, 1.2, 2.4, or 4.5 mg, once-daily liraglutide 3.0 mg, or a volume-matched placebo
They can discuss the potential benefits and risks of the medication with you and advise on the appropriate dose
and Flockhart, D.A., 1998
Br J Urol
American Diabetes Association Consensus Panel